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Background: The purpose of this study was to examine the reproducibility of both the diag-
nosis of endometrial hyperplasia (EH) or adenocarcinoma, and the histologic grading (HG) of
endometrioid adenocarcinoma (EC). Methods: Ninety-three cases of EH or adenocarcino-
mas were reviewed independently by 21 pathologists of the Gynecologic Pathology Study
Group. A consensus diagnosis was defined as agreement among more than two thirds of
the 21 pathologists. Results: There was no agreement on the diagnosis in 13 cases (14.0%).
According to the consensus review, six of the 11 EH cases (54.5%) were diagnosed as EH,
48 of the 57 EC cases (84.2%) were EC, and 5 of the 6 serous carcinomas (SC) (83.3%) were
SC. There was no consensus for the 6 atypical EH (AEH) cases. On the HG of EC, there
was no agreement in 2 cases (3.5%). According to the consensus review, 30 of the 33 G1
cases (90.9%) were G1, 11 of the 18 G2 cases (61.1%) were G2, and 4 of the 4 G3 cases
(100.0%) were G3. Conclusions: The consensus study showed high agreement for both
EC and SC, but there was no consensus for AEH. The reproducibility for the HG of G2 was
poor. We suggest that simplification of the classification of EH and a two-tiered grading sys-
tem for EC will be necessary. 
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The majority of endometrioid carcinomas (EC) cover a spec-
trum of histologically distinguishable hyperplastic lesions that
range from endometrial hyperplasia (EH) without cytologic
atypia, to EH with atypia (AEH), to well differentiated EC.1,2
This continuum of EH has been accepted by the World Health
Organization (WHO) and the International Society of Gyneco-
logic Pathologists (ISGP).3 A variety of cardinal histologic fea-
tures, such as cytologic atypia, architectural crowding or a stro-
mal desmoplastic reaction, are important to differentiate EH
without atypia from AEH, and to differentiate AEH from EC.
Accurately diagnosing the precursors to EC, which may precede
cancer by several years, presents a major challenge to pathologists.4
The Endometrial Collaborative Group has proposed the new
term ‘‘endometrial intraepithelial neoplasia’’ (EIN) to charac-
terize early malignant lesions.2,4,5 However, the term EIN has
not yet undergone rigorous prospective evaluation nor has the
reproducibility of the results with using this term been deter-
mined. It should be considered whether all well differentiated
EC and AEH would be diagnosed as EIN, as proposed by Berg-
eron et al.6
Many studies have confirmed that the histological grade is a
significant prognostic indicator for EC.7-10 The most widely used
histologic grading system for EC is the three-tiered Internation-
al Federation of Gynecology and Obstetrics (FIGO) system.9-11
Although FIGO grading has significant predictive value, some
histologic features such as the recognition of small amounts of
solid growth, distinguishing squamous from nonsquamous solid
growth and assessing the degree of nuclear atypia are difficult
to evaluate.12
Uterine serous carcinoma (SC) is also a major histological sub-
type of endometrial carcinoma. Recent studies have identified
the precursor lesions, which are classified as intraepithelial SC
or endometrial intraepithelial carcinoma (EIC) and superficial
SC, as representing the noninvasive and early invasive stages of
uterine SC, respectively.13-15 Given the aggressive behavior of
SC compared to EC and the differences in management, it is
important to correctly differentiate SC from EC of a high nucle-
ar grade, and especially owing to the overlapping histologic fea-
tures such as the papillary architecture.16
Consistency in the pathologic diagnoses of the precursor lesions
or carcinomas of the endometrium is important for choosing
the proper therapy. The objective of this study was to examine
the consensus of both the diagnosis of EH without atypia, AEH,
endometrioid and serous carcinomas, and the histologic grad-
ing of EC.
MATERIALS AND METHODS
Ninety-three cases of EH or adenocarcinoma from 13 insti-
tutions in Korea were used in this study (Table 1). The endome-
trial curettage specimens and/or the hysterectomy specimens
were independently reviewed by 21 pathologists of the Gyne-
cologic Pathology Study Group (GPSG) with using the stan-
dard ISGP/WHO criteria.3 Review of the hysterectomy speci-
mens consisted of the slides representing the most severe patholo-
gy. The biopsy review diagnoses by the study panel were subdi-
vided into the following four categories: EH without atypia,
AEH, EC and SC. The ‘‘less than EH’’ category encompassed a
spectrum of diagnoses that included secretory or proliferative
endometrium, benign polyps and inactive endometrium. The
cases placed in the ‘‘less than EH’’ category were excluded from
this study. For the EC cases, the histologic grade based on the
FIGO grading system was also reviewed.11
The study panel diagnosis was defined as agreement among
more than half of the 21 pathologists, and a consensus diagno-





Curettage/hysterectomy   7
Total 93
Table 1. Number of endometrial curettage and hysterectomy
specimens
Fig. 1. Comparison between the study panel diagnosis and the
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RESULTS
The study panel review of the cases was interpreted as follows:
eleven of the 93 cases (11.8%) were diagnosed as EH without
atypia, six cases (6.5%) were diagnosed as AEH, 57 cases (61.3
%) were diagnosed as EC and six cases (6.5%) were diagnosed
as SC. For 13 cases (14.0%), there was no agreement on the
diagnosis. According to the consensus diagnosis, six of the 11
EH without atypia cases (54.5%) were diagnosed as EH with-
out atypia, 48 of the 57 EC cases (84.2%) were diagnosed as
EC, and 5 of the 6 SC cases (83.3%) were diagnosed as SC. For
6 AEH cases, there was no consensus on the diagnosis (Fig. 1).
According to the study panel review, 33 of the 57 EC cases
(57.9%) were G1, 18 cases (31.6%) were G2 and 4 cases (7.0%)
were G3. In 2 cases (3.5%), there was no agreement on the his-
tologic grade. According to the consensus review, 30 of the 33
G1 cases (90.9%) were G1, 11 of the 18 G2 cases (61.1%) were
G2 and 4 of the 4 G3 cases (100.0%) were G3 (Fig. 2). 
We reviewed the 34 cases that had no agreement on the diag-
nosis or no consensus (Table 2). In 20 cases (58.8%), the main
cause of discrepancy was the presence of focal lesions. Seven cases
exhibited focal crowding of architecturally abnormal, cribriform
glands in the background of EH without atypia or AEH. Five
cases had focal cytologic atypia in the background of EH (Fig.
3). For three cases, there was focal hyperplasia within an other-
wise proliferative endometrium. Three cases showed patchy
small foci of a desmoplastic stromal reaction (Fig. 4). One case
showed a focal villoglandular carcinoma component in a back-
Fig. 2. Comparison between the study panel grade and the con-























Fig. 3. One case lacking agreement on the diagnosis shows focal
cytologic atypia (arrow) in a background of endometrial hyper-
plasia (inlet).  
Fig. 4. One case lacking agreement on the diagnosis shows patchy


















Focal lesion 20 (58.8%) 
Focal crowding of cribriform 4 3
glands
Focal cytologic atypia 3 2
Focal hyperplasia 1 2
Focal desmoplastic stroma 1 2
Focal villoglandular growth 1 0
Focal squamous morules 0 1
Diffuse lesion 14 (41.2%) 
Architectural crowding with 3 9
ambiguous cribriform pattern
Extensive metaplasia 0 1
Tubuloglandular architecture 0 1 
with high grade nuclei 
Table 2. Pathologic findings of 34 cases of no agreement on the
diagnosis or no consensus
ground of AEH (Fig. 5). One EC case that lacked consensus was
a focal lesion with extensive squamous morules in a background
of stromal predecidualization with atrophic glands. Some of the
pathologists diagnosed such cases as AEH, and others diagnosed
them as EC.
In 14 cases (41.2%), there were diffuse lesions. Twelve cases
that lacked agreement on the diagnosis or no consensus showed
architectural crowding, and this was associated with early crib-
riform features (Fig. 6) and equivocal cytologic atypia, making
it difficult to differentiate AEH from low grade EC. One case
showed extensive papillary and eosinophilic metaplasia in archi-
tecturally complex or fragmented glands. One SC case that lack-
ed consensus exhibited a tubuloglandular architecture with a
high nuclear grade (Fig. 7). Two EC cases that lacked agreement
on the histologic grade showed mixed patterns of low grade and
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Fig. 7. One serous carcinoma case lacking consensus exhibits a
tubuloglandular architecture with a high nuclear grade and psam-
moma bodies. 
Fig. 8. One endometrioid carcinoma case lacking agreement on
the histologic grade shows mixed patterns of low grade (inlet) and
high grade carcinomas.
Fig. 9. One serous papillary carcinoma case is limited to a benign
endometrial polyp. The high power view shows a high nuclear
grade (inlet).
Fig. 6. One case lacking agreement on the diagnosis shows focal
crowding of architecturally abnormal glands with early cribriform
features in a background of endometrial hyperplasia without atypia. 
Fig. 5. One case lacking agreement on the diagnosis shows a
focal villoglandular carcinoma component in a background of
atypical endometrial hyperplasia (inlet).
high grade carcinoma (Fig. 8).
DISCUSSION
The WHO 4-class EH classification is currently widely accept-
ed, and it primarily divides hyperplasias into those with and
those without cytologic atypia, while the degree of glandular
crowding (simple vs complex) has secondary importance. Regard-
ing the hyperplastic categories without atypia, differentiating
between simple and complex hyperplasia is not reproducible.
In addition, these two categories have essentially the same prog-
nosis, and their differentiation is not helpful and it may even
be confusing to the clinician.6 EH without atypia, whether sim-
ple or complex, is likely to respond to hormonal therapy.17,18 In
this consensus study, the interobserver reproducibility for the
classification of EH cases into simple or complex was very poor,
so we did not classify EH as simple or complex. 
According to the previous consensus studies, the reproducibili-
ty for the key assessment measure of the presence or absence of
cytologic atypia is also poor.19,20 Several expert panels have empha-
sized the considerable interobserver and intraobserver variabili-
ty using these systems, and this underlined the difficulty of mak-
ing the diagnosis of premalignant changes of the endometrium
on biopsy specimens.6,21 AEH has been reported to be a poorly
reproducible diagnosis, with experts differing in significant
proportions of cases not only for the referring pathologists but
also with each others.19,20,22
The factors that contribute to low reproducibility include: 1)
multiple independent criteria to classify a lesion because each
pathologist must assign a relative value or weight to each poten-
tially conflicting criterion, 2) the fragmentary nature of the curet-
tage specimens, 3) the presence of borderline lesions, 4) the uncer-
tainty about the significance of focal hyperplasia, 5) the inade-
quacy of descriptions and the lack of understanding of the terms
used to define the architectural or cytological atypia, and 6) the
difficulty associated with the translation of verbal descriptions
into light microscopic images and the associated interobserver
reproducibility of the translations.23
In this consensus study, six of the 11 EH cases without atyp-
ia (54.5%) were diagnosed as EH without atypia and 48 of the
57 EC cases (84.2%) were diagnosed as EC. For the 6 AEH
cases, there was no consensus on the diagnosis. These results are
comparable to those of Bergeron et al.6 For 34 cases of this study,
there was no agreement on the diagnosis or no consensus. The
main cause of discrepancy was the presence of focal lesions in
20 cases (58.8%). Seven cases exhibited focal crowding of archi-
tecturally abnormal, partly cribriform glands in the background
of EH without atypia or AEH. In 14 cases (41.2%), there were
diffuse lesions. Twelve cases that lacked agreement on the diag-
nosis or no consensus showed architectural crowding that was
associated with early cribriform features and equivocal cytolog-
ic atypia, which made it difficult to differentiate AEH from low
grade EC. Differentiation between AEH and EC was problem-
atic, especially when the lesions were focal or patchy in distri-
bution.
According to the GOG study on the diagnosis of AEH in
2006, a panel of 3 GOG pathologists concurred with the refer-
ring diagnosis for only 39% of the patients. The mean percent-
age of agreement was the lowest for complex hyperplasia and
for AEH.23 There was a lack of agreement for the diagnoses of
complex hyperplasia and AEH, and a lack of reproducibility for
the recognition of the histologic feature of the stromal alterations
and the cribriform pattern of growth that are used to differenti-
ate AEH from well differentiated EC. Thus, the histologic clas-
sification needs to be simplified by inclusion of a combined cat-
egory, called EH, for simple and complex hyperplasia, and also
a combined category, called endometrioid neoplasia, for AEH
and well differentiated EC. The diagnoses of EH and endometri-
oid neoplasia are highly reproducible between observers from
different institutions.6
EH includes ‘‘benign EH’’ caused by protracted estrogen
exposure and an ‘‘EIN’’ category of monoclonal premalignant
disease.25 EIN is a precursor to EC, and the former is character-
ized by monoclonal growth of the mutated cells, a distinctive
histopathologic appearance by its altered cytology and crowded
architecture. EIN has a 45-fold elevated cancer risk.4 EIN is a
clonal proliferation of architecturally and cytologically altered
premalignant endometrial glands that are prone to malignant
transformation to EC. EIN lesions are noninvasive, genetically
altered neoplasms that arise focally and they may convert to a
malignant phenotype upon acquisition of additional genetic
damage.5
The diagnostic criteria of EIN include glandular crowding
with an area of glands greater than the stroma. The cytology of
the architecturally crowded area is different from the background
and it is clearly abnormal. The area of an EIN lesion that meets
the architectural and cytologic criteria for diagnosis must mea-
sure a minimum of 1 mm at the maximum dimension, and this
is a scale that usually encompasses more than 5-10 glands.6
Although the foci of EC seem to have developed from the EIN,
the distinction between EIN and EC is of clinical importance.
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EIN lesions are composed of clusters of individually recogniz-
able glands with a simple, but often pseudostratified lining
epithelium, whereas EC may have one or more specific patterns
not seen in EIN, such as solid, cribriform or complex interlac-
ing mazelike growth.24 The EIN classification is much stronger
than the WHO classification for predicting cancer outcomes
during follow-up.24 Even though we did not apply the EIN cri-
teria in this series, the discrepancy have might been reduced if
the EIN classification was used. 
Although the three-tired FIGO grading has significant pre-
dictive value for EC, the reproducibility of the G2 FIGO grad-
ing is limited. A binary architectural grading system has been
proposed based on the amount of solid growth, the pattern of
myometrial invasion and the presence of necrosis.12 According
to this system, a tumor is classified as high grade if at least two
of the following three criteria were present: 1) more than 50%
solid growth (without distinction of squamous from nonsqua-
mous epithelium), 2) a diffusely infiltrative, rather than expan-
sive, growth pattern, and 3) tumor cell necrosis. For tumors
that were confined to the endometrium, only the percent of solid
growth and necrosis were evaluated, and those tumors with both
solid growth of more than 50% and necrosis were considered as
high grade.12 The recently proposed simple architectural binary
grading system that divides tumors into low-grade lesions and
high-grade lesions based on the proportion of solid growth (<
or=50% or >50%) has been shown to have superior prognostic
power and greater reproducibility.26 According to the consensus
review in this study, 30 of the 33 G1 cases (90.9%) were G1,
11 of the 18 G2 cases (61.1%) were G2 and 4 of the 4 G3 cases
(100.0%) were G3. In this series, the consensus for the G2 cases
was poor.
Uterine SC can exhibit an architecturally, well-differentiated
tubuloglandular morphology with or without an accompany-
ing papillary growth pattern. These features make it difficult
to distinguish SC from EC. Because of the aggressiveness of SC,
it is important to correctly classify endometrial carcinomas that
exhibit tubuloglandular architecture with a high nuclear grade.27
In this study, 5 of the 6 SC cases (83.3%) were SC according to
the consensus diagnosis. One case that had no consensus exhib-
ited tubuloglandular architecture with a high nuclear grade.
Immunohistochemical staining facilitates the distinction of SC
from EC. The combination of no p53 expression, a positive PR
expression and the loss of PTEN best distinguishes between EC
and SC.27 Point mutations in the p53 suppressor gene might
partly explain the rapid growth of this malignant tumor and
its unfavorable outcome.28,29 The association of an endometrial
polyp with SC was first reported in a study by Silva and Jenkin30
in which 16 patients with superficial SC involving an endome-
trial polyp were described. In this current study, the three serous
papillary carcinomas were limited to the benign endometrial
polyps (Fig. 9). The carcinoma was exclusively composed of a
serous papillary subtype in 2 cases and was admixed with an
endometrioid type in one case. Microscopically, the tumors were
architecturally characterized by complex broad or thin papillae
with epithelial stratification, and they were cytologically char-
acterized by pleomorphic, hyperchromatic nuclei and promi-
nent nucleoli with occasional macronucleoli. The nuclei were
bizarre, and some cells had a hobnail appearance.
Although our observations were based on a small number of
cases, this study suggests that simplification of the EH classifi-
cation system is sorely needed. Other studies of a two-tiered
grading system compared with the current 3 level grading sys-
tem for EC will be useful. Future studies based on the results
from this study will include a biomarker analysis in an effort to
characterize those endometrial lesions that are predictive of car-
cinoma. 
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